Dr. Silke V. Niederhaus, MD

Dr. Niederhaus practices at University of Maryland Shore Medical Center at Easton in Easton, Maryland, part of University of Maryland Medical System.

Dr. Niederhaus' NPI, 1639127293, was assigned on May 5, 2006. Dr. Niederhaus holds Maryland license D0074647.

Dr. Niederhaus' primary practice is University of Maryland Shore Medical Center at Easton, at 219 South Washington Street, Easton, MD 21601 in Talbot County. The practice phone is (410) 822-1000.

Dr. Niederhaus' primary practice is University of Maryland Shore Medical Center at Easton in Easton, Maryland, part of University of Maryland Medical System. Dr. Niederhaus is also affiliated with University of Maryland Medical Center. The medical group on file is University of Maryland Surgical Care. Dmand AI also links Dr. Niederhaus to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Niederhaus practices, 5 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Niederhaus' primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dmand AI has Dr. Niederhaus' licenses on file in 2 states: Maryland and Wisconsin.

CMS data shows 298 Medicare services from Dr. Niederhaus across 6 procedure codes in 2024, for 140 Medicare patients. Medicare paid $58,001 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 140 Medicare patients who saw Dr. Niederhaus in 2024. The largest group is under 65, with 78 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 8.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Niederhaus' median patient age at 64, with 43% women.

In 2024, Dr. Niederhaus wrote 31 Medicare Part D claims for 23 patients. 100% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $59 in total drug cost. In 2023, CMS named 29 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Niederhaus for performance year 2024, reported as part of a group. Dr. Niederhaus accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Niederhaus, published from 2011 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Kidney Transplantation, Pancreas Transplantation and Living Donors. Dr. Niederhaus has published most often in Am J Transplant. Dr. Niederhaus' most frequent co-authors are Jon S. Odorico, MD, Jonathan Scott Bromberg, MD and Stephen T. Bartlett, MD.

CMS Open Payments shows 7 general payments to Dr. Niederhaus from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $236.